Jianjie Wu

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Integrated Analysis of Single-Cell RNA Sequencing and Machine Learning Reveals a T Cell-Specific PANoptosis Signature Predicting Prognosis and Immunotherapy in Prostate Cancer.

Integrated Analysis of Single-Cell RNA Sequencing and Machine Learning Reveals a T Cell-Specific PANoptosis Signature Predicting Prognosis and Immunotherapy in Prostate Cancer.

Journal: Human mutation

Published: August 08, 2025

A secreted signature discriminates indolent from aggressive prostate tumors.

A secreted signature discriminates indolent from aggressive prostate tumors.

Journal: World journal of urology

Published: April 10, 2025

UHMK1 Promotes Prostate Cancer Progression through a Positive Feedback Loop with MTHFD2.

UHMK1 Promotes Prostate Cancer Progression through a Positive Feedback Loop with MTHFD2.

Journal: Oncology research

Published: March 04, 2025

miR-145-enriched BMSCs-derived exosomes ameliorate neurogenic erectile dysfunction in aged rats via TGFBR2 inhibition.

miR-145-enriched BMSCs-derived exosomes ameliorate neurogenic erectile dysfunction in aged rats via TGFBR2 inhibition.

Journal: Regenerative therapy

Published: February 14, 2025

Harnessing machine learning and multi-omics to explore tumor evolutionary characteristics and the role of AMOTL1 in prostate cancer.

Harnessing machine learning and multi-omics to explore tumor evolutionary characteristics and the role of AMOTL1 in prostate cancer.

Journal: International journal of biological macromolecules

Published: September 10, 2024

Caveolin-1 scaffolding domain-derived peptide enhances erectile function by regulating oxidative stress, mitochondrial dysfunction, and apoptosis of corpus cavernosum smooth muscle cells in rats with cavernous nerve injury.

Caveolin-1 scaffolding domain-derived peptide enhances erectile function by regulating oxidative stress, mitochondrial dysfunction, and apoptosis of corpus cavernosum smooth muscle cells in rats with cavernous nerve injury.

Journal: Life sciences

Published: March 07, 2024

Knockdown of programmed cell death factor 4 restores erectile function by attenuating apoptosis in rats with bilateral cavernous nerve crush injury.

Knockdown of programmed cell death factor 4 restores erectile function by attenuating apoptosis in rats with bilateral cavernous nerve crush injury.

Journal: Andrology

Published: October 09, 2023

Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer.

Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer.

Journal: Journal of translational medicine

Published: August 11, 2023

Inflammation-related signature for prognostic prediction, tumor immune, genomic heterogeneity, and drug choices in prostate cancer: Integrated analysis of bulk and single-cell RNA-sequencing.

Inflammation-related signature for prognostic prediction, tumor immune, genomic heterogeneity, and drug choices in prostate cancer: Integrated analysis of bulk and single-cell RNA-sequencing.

Journal: Heliyon

Published: April 24, 2023

Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer.

Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer.

Journal: Frontiers in immunology

Published: December 13, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026